Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Operating Leases (2021 - 2025)

Rxo (RXO) has disclosed Operating Leases for 5 consecutive years, with $191.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 35.47% year-over-year to $191.0 million, compared with a TTM value of $191.0 million through Dec 2025, down 35.47%, and an annual FY2025 reading of $191.0 million, down 35.47% over the prior year.
  • Operating Leases was $191.0 million for Q4 2025 at Rxo, down from $202.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $296.0 million in Q4 2024 and bottomed at $93.0 million in Q4 2021.
  • Average Operating Leases over 5 years is $165.7 million, with a median of $150.0 million recorded in 2024.
  • The sharpest move saw Operating Leases soared 108.8% in 2024, then crashed 35.47% in 2025.
  • Year by year, Operating Leases stood at $93.0 million in 2021, then grew by 22.58% to $114.0 million in 2022, then rose by 28.07% to $146.0 million in 2023, then skyrocketed by 102.74% to $296.0 million in 2024, then plummeted by 35.47% to $191.0 million in 2025.
  • Business Quant data shows Operating Leases for RXO at $191.0 million in Q4 2025, $202.0 million in Q3 2025, and $201.0 million in Q2 2025.